InvestorsHub Logo
Followers 25
Posts 2297
Boards Moderated 0
Alias Born 11/10/2012

Re: None

Saturday, 08/23/2014 10:55:34 PM

Saturday, August 23, 2014 10:55:34 PM

Post# of 108192
DD on July 28,2014 GlobeNewswire ADXS announced that it has received a notice of allowance from the Japan Patent Office for a patent application related to the ADXS proprietary Lm-LLO cancer immunotherapy platform technology.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News